NCT01589562View on ClinicalTrials.gov

Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy
Interventions
DRUG

Megace 800mg/20ml

Megestrol acetate 800mg/20ml, Suspension, Single dose

DRUG

DW-ES(B) 625mg/5ml

Megestrol acetate 625mg/5ml, Nano suspension, Single dose

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT01589562 - Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition | Biotech Hunter | Biotech Hunter